ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 569

Is the Oral Microbiome Involved in the Pathogenesis of Sjogren’s Syndrome?

Taco A van der Meulen1, Frans G.M. Kroese2, S.C. Liefers2, Arnau Vich Vila3, Hermie J.M. Harmsen4, Hendrika Bootsma2, Fred K.L. Spijkervet1 and Arjan Vissink5, 1Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Gastroenterology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: microbiome, oral and pathogenesis, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Sjögren's Syndrome Poster I: Translational Research

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Environmental factors involved in the pathogenesis of primary Sjögren’s syndrome (pSS) are still largely unknown. The oral cavity is the microbial habitat closest to the salivary glands – the most affected tissue in pSS. Hypofunction of the salivary glands is the major cause underlying symptoms of a dry mouth (xerostomia), occurring in over 90% of the patients with pSS. The aim of our study was to explore whether the oral microbiome, in particular the bacterial composition and/or the presence of bacterial species, is specific for the oral microbiome of patients with pSS.

Methods: To assess whether changes in the oral microbiome of pSS patients are a cause of pSS or an effect of oral dryness, we included two control groups: patients with oral dryness not diagnosed as pSS (non-SS sicca patients) and population based controls. We collected a swab from the buccal mucosa of 82 patients with oral dryness referred to our outpatient clinic for a complete diagnostic work-up for pSS. After completing the diagnostic workup, 32 patients could be classified as pSS according to the 2002 AECG classification criteria and 50 patients as non-SS sicca. The bacterial composition of the buccal mucosa samples was determined with 16S rRNA sequencing. Buccal mucosa swab samples from a population based cohort study were used as population controls (n=118).

Results: Mean unstimulated whole salivary flow rates in pSS and non-SS sicca patients were 0.09 and 0.17 mL/min respectively. Significantly less 16S rRNA reads per sample were obtained from the buccal swab samples of patients with oral dryness (pSS and non-SS sicca together) compared to population controls (p<0.0001). Also the diversity of the bacterial composition from the buccal mucosa was significantly lower in pSS and non-SS sicca patients than in population controls (p=0.01 and p<0.001 respectively), but no difference was observed between pSS and non-SS sicca patients. Principal coordinate analysis showed no evident separation of the individual samples between the three different study groups, but the buccal mucosa bacterial communities from pSS patients were significantly more dissimilar to those from population controls than non-SS sicca patients from population controls (p=0.028). Multivariate analysis showed highly significant associations between oral dryness and the genera Olsenella, Cryptobacterium and Fretibacterium – all which have been associated with periodontal disease – since these genera were only detected in samples from the buccal mucosa of patients with oral dryness and not in population controls (p-value <0.005). However, no oral bacterial taxa were specifically associated with pSS.

Conclusion: Patients with pSS have a dysbiosis of the oral microbiome, viz. a reduced diversity and increase of pathogenic bacteria. We presume that dysbiosis in the oral microbiome of patients with pSS is largely an effect of oral dryness and not a causal factor in the pathogenesis of pSS. On top of this dysbiosis as a consequence of oral dryness, there might be a specific effect of pSS on the diversity of the oral microbiome.


Disclosure: T. A. van der Meulen, None; F. G. M. Kroese, None; S. C. Liefers, None; A. Vich Vila, None; H. J. M. Harmsen, None; H. Bootsma, None; F. K. L. Spijkervet, None; A. Vissink, None.

To cite this abstract in AMA style:

van der Meulen TA, Kroese FGM, Liefers SC, Vich Vila A, Harmsen HJM, Bootsma H, Spijkervet FKL, Vissink A. Is the Oral Microbiome Involved in the Pathogenesis of Sjogren’s Syndrome? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/is-the-oral-microbiome-involved-in-the-pathogenesis-of-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-the-oral-microbiome-involved-in-the-pathogenesis-of-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology